Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
4.75M
-
Shares change
-
+1.03M
-
Total reported value, excl. options
-
$6.04M
-
Value change
-
+$1.22M
-
Put/Call ratio
-
0.71
-
Number of buys
-
10
-
Number of sells
-
-18
-
Price
-
$1.27
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q3 2022
38 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q3 2022.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.75M shares
of 153M outstanding shares and own 3.1% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (2.37M shares), WELLS FARGO & COMPANY/MN (769K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (378K shares), VANGUARD GROUP INC (240K shares), Cannell & Co. (206K shares), Endurant Capital Management LP (130K shares), GEODE CAPITAL MANAGEMENT, LLC (124K shares), MILLENNIUM MANAGEMENT LLC (118K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (100K shares), and RENAISSANCE TECHNOLOGIES LLC (56.9K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.